Lv1
15 积分 2021-10-07 加入
Loss of TIM4-Dependent Efferocytosis in Kupffer Cells Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis
2个月前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
3个月前
已完结
Elucidating pathway-selective biased CCKBR agonism for Alzheimer’s disease treatment
3个月前
已完结
Novel Potent and Selective Bile Acid Derivatives as TGR5 Agonists: Biological Screening, Structure−Activity Relationships, and Molecular Modeling Studies
4个月前
已完结
Identification of membrane-type receptor for bile acids (M-BAR)
4个月前
已完结
Rifaximin alleviates MCD diet-induced NASH in mice by restoring the gut microbiota and intestinal barrier
8个月前
已完结
Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet–induced rat steatohepatitis
8个月前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
8个月前
已完结
Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
8个月前
已完结
Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study
8个月前
已完结
皖公网安备34019202002308
